Weiqin Jiang

5.8k total citations · 3 hit papers
129 papers, 4.4k citations indexed

About

Weiqin Jiang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Weiqin Jiang has authored 129 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 39 papers in Oncology and 24 papers in Cancer Research. Recurrent topics in Weiqin Jiang's work include Metabolism, Diabetes, and Cancer (15 papers), Diet and metabolism studies (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Weiqin Jiang is often cited by papers focused on Metabolism, Diabetes, and Cancer (15 papers), Diet and metabolism studies (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Weiqin Jiang collaborates with scholars based in United States, China and United Kingdom. Weiqin Jiang's co-authors include Henry J. Thompson, Zongjian Zhu, Linfu Zhou, John N. McGinley, Yuanyuan Zhou, Ying Li, Zhihua Sui, Weijia Fang, Howard E. Ganther and Yi Zheng and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Weiqin Jiang

124 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma

2019 392 citations Yi Zheng, Tingting Wang et al. Journal for ImmunoTherapy of Cancer profile →
MAPK/JNK signalling: a potential autophagy regulation pathway

2015 353 citations Weiqin Jiang et al. profile →
Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy

2021 225 citations Weiqin Jiang, Yinjun He et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiqin Jiang United States	35	2.0k	1.2k	838	556	496	129	4.4k
Santosh K. Sandur India	34	3.1k 1.5×	858 0.7×	678 0.8×	377 0.7×	564 1.1×	88	5.9k
Jacques Magdalou France	43	3.0k 1.5×	1.2k 1.0×	563 0.7×	493 0.9×	348 0.7×	259	7.5k
Peiying Yang United States	43	2.5k 1.2×	778 0.7×	1.1k 1.3×	398 0.7×	217 0.4×	163	5.5k
Manoj K. Pandey United States	34	3.1k 1.6×	1.3k 1.1×	950 1.1×	299 0.5×	618 1.2×	79	6.2k
Stefania Catalano Italy	49	2.6k 1.3×	1.4k 1.2×	1.4k 1.7×	809 1.5×	215 0.4×	149	5.8k
Mauro Piantelli Italy	44	2.7k 1.4×	1.6k 1.4×	767 0.9×	444 0.8×	339 0.7×	180	6.3k
Shousong Cao United States	39	2.5k 1.2×	1.3k 1.1×	677 0.8×	206 0.4×	259 0.5×	113	4.7k
Takahiro Seki Japan	30	2.5k 1.3×	695 0.6×	735 0.9×	649 1.2×	321 0.6×	59	4.8k
Yuan‐Soon Ho Taiwan	40	2.7k 1.4×	728 0.6×	772 0.9×	389 0.7×	372 0.8×	121	4.8k
Christopher E. Goldring United Kingdom	43	3.8k 1.9×	743 0.6×	814 1.0×	406 0.7×	311 0.6×	124	7.1k

Countries citing papers authored by Weiqin Jiang

Since Specialization

Citations

This map shows the geographic impact of Weiqin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqin Jiang more than expected).

Fields of papers citing papers by Weiqin Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqin Jiang. The network helps show where Weiqin Jiang may publish in the future.

Co-authorship network of co-authors of Weiqin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqin Jiang. A scholar is included among the top collaborators of Weiqin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqin Jiang. Weiqin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiang, Yinjun He, Wenguang He, et al.. (2024). Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer. Therapeutic Advances in Medical Oncology. 16. 2669771–2669771.

Wu, Guosheng, Long Zhao, Weiqin Jiang, et al.. (2023). Intestinal Autotransplantation for Locally Advanced or Locally Recurrent Colon Cancer Invading Superior Mesenteric Artery. Annals of Surgery. 281(3). 462–468. 2 indexed citations

He, Yinjun, Xiang Zhang, Ming Zhu, et al.. (2023). Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer. Journal of Translational Medicine. 21(1). 46–46. 25 indexed citations

Zheng, Yi, Tingting Wang, Xiaoxuan Tu, et al.. (2019). Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 7(1). 193–193. 392 indexed citations breakdown →

Cong, Yan, Xiaoxuan Tu, Wei Wu, et al.. (2019). Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?. World Journal of Clinical Cases. 7(11). 1253–1261. 13 indexed citations

Zhang, Hangyu, Rujiao Liu, Lulu Liu, et al.. (2018). Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients. Translational Oncology. 12(3). 426–431. 37 indexed citations

Jiang, Weiqin, Yifei Shen, Yongfeng Ding, et al.. (2017). A naive Bayes algorithm for tissue origin diagnosis (TOD‐Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system. International Journal of Cancer. 142(2). 357–368. 21 indexed citations

Zhu, Zongjian, Weiqin Jiang, Matthew D. Thompson, et al.. (2015). Effects of Metformin, Buformin, and Phenformin on the Post-Initiation Stage of Chemically Induced Mammary Carcinogenesis in the Rat. Cancer Prevention Research. 8(6). 518–527. 26 indexed citations

Matthews, Shawna B., Zongjian Zhu, Weiqin Jiang, et al.. (2014). Excess Weight Gain Accelerates 1-Methyl-1-Nitrosourea–Induced Mammary Carcinogenesis in a Rat Model of Premenopausal Breast Cancer. Cancer Prevention Research. 7(3). 310–318. 6 indexed citations

10.

Zhu, Zongjian, et al.. (2012). Effects of Energy Restriction and Wheel Running on Mammary Carcinogenesis and Host Systemic Factors in a Rat Model. Cancer Prevention Research. 5(3). 414–422. 34 indexed citations

11.

Jiang, Weiqin, et al.. (2012). Identification of a Molecular Signature Underlying Inhibition of Mammary Carcinoma Growth by Dietary N-3 Fatty Acids. Cancer Research. 72(15). 3795–3806. 58 indexed citations

12.

Jiang, Weiqin, Weibin Wang, Fangfang Fu, et al.. (2012). A more sensitive platform for the detection of low-abundance BRAFV600E mutations. Molecular and Cellular Biochemistry. 366(1-2). 49–58. 8 indexed citations

13.

Zhu, Zongjian, Weiqin Jiang, John N. McGinley, et al.. (2011). Mammary Gland Density Predicts the Cancer Inhibitory Activity of the N-3 to N-6 Ratio of Dietary Fat. Cancer Prevention Research. 4(10). 1675–1685. 25 indexed citations

14.

Jiang, Weiqin, Zongjian Zhu, & Henry J. Thompson. (2009). Effects of Physical Activity and Restricted Energy Intake on Chemically Induced Mammary Carcinogenesis. Cancer Prevention Research. 2(4). 338–344. 30 indexed citations

15.

Zhu, Zongjian, et al.. (2009). Abstract #8: A translational research paradigm by using pharmacological agents that will mimic or couple with dietary energy restriction for breast cancer prevention. Cancer Research. 69. 8–8. 1 indexed citations

16.

Zhu, Zongjian & Weiqin Jiang. (2008). Selenium in prevention of cancer: evidence and mechanism (特集セレンの多彩な機能). 19(4). 282–289. 11 indexed citations

17.

Jiang, Weiqin, Zongjian Zhu, & Henry J. Thompson. (2008). Modulation of the activities of AMP‐activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2‐deoxyglucose. Molecular Carcinogenesis. 47(8). 616–628. 27 indexed citations

18.

Gao, Lianghui, et al.. (2005). A Rat Model of Chronic Allograft Liver Rejection. Transplantation Proceedings. 37(5). 2327–2332. 9 indexed citations

19.

Thompson, Henry J., Jerianne Heimendinger, Scot Sedlacek, et al.. (2005). 8-Isoprostane F2α excretion is reduced in women by increased vegetable and fruit intake. American Journal of Clinical Nutrition. 82(4). 768–776. 65 indexed citations

20.

Jiang, Weiqin, Zongjian Zhu, John N. McGinley, & Henry J. Thompson. (2004). Adrenalectomy Does Not Block the Inhibition of Mammary Carcinogenesis by Dietary Energy Restriction in Rats. Journal of Nutrition. 134(5). 1152–1156. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact